Skip to content

AtriClip® PRO•V™ LAA Exclusion System PROV45 (REF A000973)Recalls & reported problems

Atricure, Inc. · AtriClip® PRO•V™ LAA Exclusion System 45 · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818354015140), received between Jun 16, 2022 and Jun 16, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Misassembled” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Misassembled1

Patient problems

  • Cardiac Perforation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 16, 2022Misassembled; Misassembled

    ON (B)(6) 2022 DURING A LEFT ATRIAL APPENDAGE (LAA) EXCLUSION PROCEDURE, T WAS NOTICED THAT THE DACRON WAS NOT COMPLETELY COVERING THE PROV45 CLIP. AN INJURY TO THE LAA WAS OBSERVED. THE PATIENT WAS PLACED BACK ON-PUMP AND THE PROCEDURE WAS CONVERTED TO A STERNOTOMY TO REPAIR THE LAA. AN ATRICLIP PRO1 WAS PLACED ON THE THE LAA SUCCESSFULLY. THERE WERE NO ADDITIONAL PATIENT COMPLICATIONS REPORTED.

    Patient problems: Cardiac Perforation

    MAUDE report 14717573 ↗

Other Clip, Implantable devices

All Clip, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page